FDA Grants Direct Biologics Regenerative Medicine Advanced Therapy (RMAT) Designation for the use of ExoFlo in COVID-19 Related ARDS
AUSTIN, Texas, April 13, 2022 /PRNewswire/ — Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform
Read More